H.C. Wainwright Keeps Their Buy Rating on Lexicon Pharmaceuticals (LXRX)
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report), ...
Lam Research Corp. stock underperforms Wednesday when compared to competitors
This was the stock's second consecutive day of losses.
Lam Research (LRCX) – $1.2 Billion Bet on India’s Semiconductor Future!
We recently published a list of 10 AI Stocks Analysts Are Watching: Latest Ratings and News. In this article, we are going to ...
Lam Research Corporation (LRCX): A Bull Case Theory
We came across a bullish thesis on Lam Research Corporation (LRCX) on Substack by Long-Term Pick. In this article, we will ...
Lam Research Corp. stock underperforms Monday when compared to competitors despite daily gains
Lam Research Corp. closed 25.90% short of its 52-week high of $113.00, which the company achieved on July 11th.